AS

Alun John Smith

RE Respivert: 3 patents #25 of 50Top 50%
KL Kalvista Pharmaceuticals Limited: 2 patents #11 of 38Top 30%
OP Osi Pharmaceuticals: 1 patents #106 of 181Top 60%
Overall (All Time): #702,840 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11613527 Enzyme inhibitors Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Simon Teanby Hodgson, Alessandro MAZZACANI +4 more 2023-03-28
9745306 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitors Rudy Laurent Maria Broeckx, Alex Herman Copmans, David Michel Adrien Taddei, Stuart Thomas Onions 2017-08-29
9556184 Phosphoinositide 3-kinase inhibitors David Michel Adrien Taddei, Stuart Thomas Onions, Alex Herman Copmans, Rudy Laurent Maria Broeckx 2017-01-31
9533987 Heterocyclic derivates Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Simon Teanby Hodgson, Iain Robert MILLER +2 more 2017-01-03
9227977 Phosphoinositide 3-kinase inhibitors David Michel Adrien Taddei, Stuart Thomas Onions, Alex Herman Copmans, Rudy Laurent Maria Broeckx 2016-01-05
7829717 (Arylamidoaryl)squaramide compounds Arlindo L. Castelhano, Andrew P. Crew, Hanqing Dong, An-Hu Li, Li Qiu +2 more 2010-11-09
7439256 (Arylamidoaryl) cyanoguanidine compounds Arlindo L. Castelhano, Andrew P. Crew, Hanqing Dong, An-Hu Li, Li Qiu 2008-10-21